expressionedits is a startup based in the United Kingdom, most recent round Seed, 1 tracked investor.
Based in the United Kingdom, expressionedits is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
ExpressionEdits develops AI-driven genetic syntax optimization technology that uses patented intronization to enhance gene expression, enabling efficient production of complex therapeutic proteins and advancing cell and gene therapy applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.